BTL Establishes New Laser Division, Introduces EXOLASE ONE®
Medical device company BTL has launched a new laser-focused division and introduced EXOLASE ONE®, which it claims is the world's first Fused Erbium Laser for facial rejuvenation. The technology aims to set a new standard in laser skin treatment.
Medical device company BTL has established a new division dedicated to laser technology. The company also unveiled EXOLASE ONE®, which it states is the world's first Fused Erbium Laser designed for facial rejuvenation applications.
According to BTL, EXOLASE ONE® utilizes proprietary technology that combines multiple wavelengths into a single beam. This development is intended to establish a new benchmark for laser-based facial treatments. The company suggests this innovation will enhance patient outcomes in aesthetic procedures.
The formation of this specialized division and the introduction of the EXOLASE ONE® device align with BTL's strategy to broaden its portfolio of energy-based medical equipment. This move aims to address the growing market demand for advanced aesthetic solutions. Specific technical specifications and clinical data regarding the device were not detailed in the initial announcement.